Deal Type

Baird Capital, the global venture capital, growth equity and private equity investor, has closed an oversubscribed continuation vehicle to support Blue Matter Consulting, a...

Fresenius, a global, therapy-focused healthcare company, together with SAP, is investing in Avelios Medical, a Munich-based company developing a next-generation, cloud-native hospital information system. The...

Columna Capital has acquired a majority stake in Evidenze Group, a Spain‑based full‑service CRO, from Buenavista Equity Partners. The UK‑based pan‑European lower mid‑market investor...

Stockholm-listed, Sweden-based international healthcare and diagnostic services company, Medicover, has signed a new €450m (US$526m) syndicated revolving credit facility agreement. The new facility replaces...

Euronext-listed UCB, a Belgium-based global biopharmaceutical company focused on severe neurological and immunological conditions, is to acquire Candid Therapeutics, a US-based privately held clinical-stage biotechnology...

Euronext-listed UCB, a Belgium-based global biopharmaceutical company focused on severe neurological and immunological conditions, has acquired the Patients Insights business of IMIDomics, a US-based...

New York-listed Lazard, a global financial advisory and asset management firm, is acquiring Campbell Lutyens, a UK-based global private markets advisor focused on fund...

Greenpeak Partners‑backed athagoras, a Germany‑based platform of life sciences consultants, has added Ecker + Ecker and Accessus Health to the group, representing a clear...

Demetra,  an Italy-based independent medical company providing anti-infective cements, spacers and biomaterials for orthopaedic applications, has acquired Maxxspine Innovative, a German-based company specialising in advanced...

Chiesi Group, an Italy-based, family-controlled, international research-focused biopharmaceutical group and certified B Corp, is acquiring Nasdaq-listed KalVista Pharmaceuticals, a global pharmaceutical company focused on...